Effect of alcohol consumption on diagnosis of liver cirrhosis patients’ survival at a University Hospital in Medellín
DOI:
https://doi.org/10.22516/25007440.281Keywords:
Cirrhosis, alcohol consumption, alcoholism, mortality, chronic liver diseaseAbstract
Worldwide, alcohol consumption is a well-known risk factor for premature death, morbidity and disability. Records of mortality associated with alcohol consumption are not centralized. The aim of this study was to record the mortality rate associated with alcohol intake in patients with cirrhosis who were treated at a university hospital in the city of Medellin.
Materials and methods: We included 163 patients who had been diagnosed with cirrhosis in the outpatient hepatology clinic of a 277 bed referral hospital in Medellín. Patients were monitored until 2016. Sociodemographic, paraclinical and clinical variables were measured. Alcohol consumption was considered at the beginning of the follow-up. Survival and complications associated with cirrhosis were described and recorded for patients who consumed alcohol as well as for those who did not, and then the two groups were compared.
Results: One hundred sixty-three patients were followed until December 2016. The mortality rate among those who consumed alcohol was 51% while it was only 39% for those who did not consume alcohol (P = 0.19). Comparison of complications of cirrhosis showed that 68% of alcohol users developed ascites vs. 43% of non-consumers (P = 0.01); 40.6% of alcohol users developed encephalopathy vs. 13.5% of non-consumers (P = 0.00); and 29% of alcohol users developed hepatocellular carcinoma (HCC) vs. 17% of non-consumers (P = 0.08). In the subgroup analysis, patients with hepatitis C who consumed alcohol had a higher mortality rate than patients who did not consume alcohol (OR: 33, 95% CI: 1.06 to 1023).
Conclusions: Although alcohol consumption was not related to increased mortality among patients with cirrhosis in this study, increased mortality was observed in the subgroup of patients with hepatitis C.
Downloads
Languages:
esReferences
Estrategia Nacional De Respuesta Integral Frente Al Consumo De Alcohol En Colombia. 2013;1–69. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/ENT/estrategia-nacional-alcohol-colombia.pdf
Roulot D, Costes JL, Buyck JF, Warzocha U, Gambier N, Czernichow S, et al. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years. Gut 2010;60:977–984.
https://doi.org/10.1136/gut.2010.221382
European Association For The Study Of The Liver. EASL clinical practical guidelines: management of alcoholic liver disease. Journal of Hepatology. 2012 Aug 31;57(2):399-420.
https://doi.org/10.1016/j.jhep.2012.04.004
Sheila Sherlock D. Alcoholic liver disease. Lancet. 1995;345(8944):227–9.
https://doi.org/10.1016/S0140-6736(95)90226-0
Yoon YH, Yi HY, Thomson PC. Liver cirrhosis mortality in the United States, 1970- 2009, surveillance Report #93. National Institute on Alcohol Abuse and Alcoholism; 2012.
Plunk AD, Syed-Mohammed H, Cavazos-Rehg P, Bierut LJ, Grucza RA. Alcohol Consumption, Heavy Drinking, and Mortality: Rethinking the J-Shaped Curve. Alcohol Clin Exp Res. 2014;38(2):471–8.
https://doi.org/10.1111/acer.12250
Dugum M, Mccullough A. Review Article Diagnosis and Management of Alcoholic Liver Disease. 2015;3:109–16.
Mathurin P, O'Grady J, Carithers RL, Phillips M, Louvet A, Mendenhall CL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut. 2011;60(2):255–60.
https://doi.org/10.1136/gut.2010.224097
Mathurin, P.; Moreno, C.; Samuel, D.; Dumortier, J.; Salleron, J.; Durand, F.; Castel, H.; Duhamel, A.; Pageaux, G.P.; Leroy, V.; Dharancy, S.; Louvet, A.; Boleslawski, E.; Lucidi, V.; Gustot, T.; Francoz, C.; Letoublon, C.; Castaing, D.; Belghiti, J.; Do JCE. Early Liver Transplantation for Severe Alcoholic Hepatitis. N Engl J Med. 2011;365:1790–800.
https://doi.org/10.1056/NEJMoa1105703
Bellentani S, Saccoccio G, Costa G, et al, Dionysus Study Group. Drinking habits as cofactors of risk for alcohol induced liver damage. Gut 1997;41:845–50.
https://doi.org/10.1136/gut.41.6.845
Chacko KR, Reinus J. Spectrum of alcoholic liver disease. Clinics in Liver Disease. 2016 Aug 31;20(3):419-27.
https://doi.org/10.1016/j.cld.2016.02.002
Saitz R. Unhealthy alcohol use. New England Journal of Medicine. 2005 Feb 10;352(6):596-607.
https://doi.org/10.1056/NEJMcp042262
Chan C, Levitsky J. Infection and Alcoholic Liver Disease. Clinics in Liver Disease. 2016 Aug 31;20(3):595-606.
https://doi.org/10.1016/j.cld.2016.02.014
Mandayam S, Jamal MM, Morgan TR. Epidemiology of alcoholic liver disease. Semin Liver Dis 2004;24:217-232.
https://doi.org/10.1055/s-2004-832936
Lieber CS, Jones DP, Decarli LM. Effects of prolonged ethanol intake: production of fatty liver despite adequate diets. J Clin Invest 1965;44: 1009-1021.
https://doi.org/10.1172/JCI105200
Albanis E, Friedman SL. Pathogenesis and Principles of Therapy. Curr Futur Treat Ther LIVER Dis. 2001;5(2):315–34.
Larkin J, Clayton MM, Liu J, et al. Chronic ethanol consumption stimulates hepa- titis B virus gene expression and replication in transgenic mice. Hepatology 2001; 34:792–7.
https://doi.org/10.1053/jhep.2001.27565
Westin J, Lagging LM, Spak F, et al. Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J Viral Hepat 2002;9:235–41.
https://doi.org/10.1046/j.1365-2893.2002.00356.x
LinCW, Lin CC, Mo LR, et al. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis. J Hepatol 2013; 58:730–5.
https://doi.org/10.1016/j.jhep.2012.11.045
Seitz H, StickeL F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer. 2007;7(8):599.
https://doi.org/10.1038/nrc2191
Jee SH, Ohrr H, Sull JW, et al. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 2004;96: 1851–6.
https://doi.org/10.1093/jnci/djh334
Chan C, Levitsky J. Infection and Alcoholic Liver Disease. Clin Liver Dis 2016;20(3):595–606.
https://doi.org/10.1016/j.cld.2016.02.014
Suárez Quintero Y. Consumo de alcohol en Colombia:¿ sabemos en qué estamos?. Rev. colomb. gastroenterol. 2015 Dec 30;30(4):387-8.
Giraldo A, Barraza M, Villa H, Martínez J, García G. Caracterización epidemiológica de pacientes con cirrosis en una consulta de gastroenterologia en Pereira, Colombia, 2009-2012. Rev Med Risaralda. 2014;20(5):86–94.
Prieto O, Jhon E, Sánchez S, Prieto O, Robin G, Rojas D, Ever L, González L, Mendivelso F. Características clínicas y descompensación en pacientes con cirrosis hepática atendidos en dos centros de hepatología en la ciudad de Bogotá DC, 2010-2014. Revista Colombiana de Gastroenterología. 2016 Jan 1;31
Santos O, Londo-o M, Marín J, Mu-oz O, Mena A, Guzmán C, et al. Colombia Médica An experience of liver transplantation in Latin America : a medical center in Colombia. 2015;46:8–13.
Cortes-Mancera F, Loureiro CL, Hoyos S, Restrepo JC, Correa G, Jaramillo S, Norder H, Pujol FH, Navas MC. Etiology and viral genotype in patients with end-stage liver diseases admitted to a hepatology unit in Colombia. Hepat Res Treat 2011 Sep 20;2011.
Singal AK, Kamath PS, Gores GJ, Shah VH. Alcoholic hepatitis: current challenges and future directions. Clin Gastroenterol Hepatol [Internet]. 2014;12(4):555-64-2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23811249%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC3883924
Chiva-Blanch G, Arranz S, Lamuela-Raventos RM ER. Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies. Alcohol Alcohol. 1;48(3):27.
Sogabe M, Okahisa T, Taniguchi T, Tomonari T, Tanaka T, Tanaka H, Nakasono M TT. Light alcohol consumption plays a protective role against non‐alcoholic fatty liver disease in Japanese men with metabolic syndrome. Liver Int 2015 Jun 1;35(6)1707-14. 1;35(6):1707–14.
Downloads
Published
How to Cite
Issue
Section
License
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
